Literature DB >> 839368

Hyperargininemia.

S D Cederbaum, K N Shaw, M Valente.   

Abstract

A 7 1/2-year-old boy had progressive psychomotor retardation, behavior disturbance, and spasticity, and had growth arrest from age three. Plasma arginine on a self-selected protein-poor diet was increased (4.05 mg/dl; nl 0.4 to 2.6), whereas urinary amino acid excretion was normal. Red blood cell arginase was less than 1% of normal in the patient and was half normal in both parents, in two normal siblings, and in his paternal grandfather. Three hours after a meal providing 2 gm protein/kg body weight, the plasma arginine value rose to 13.2 mg/dl, dibasic aminoaciduria was seen clearly for the only time, but blood ammonia concentration remained normal. We conclude that arginase deficiency in the red blood cells and probably in the liver is inherited in an autosomal recessive manner and is responsible for the clinical syndrome in this patient.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 839368     DOI: 10.1016/s0022-3476(77)80368-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

1.  Molecular genetic study of human arginase deficiency.

Authors:  W W Grody; D Klein; A E Dodson; R M Kern; P B Wissmann; B K Goodman; P Bassand; B Marescau; S S Kang; J V Leonard
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

2.  Differential expression of the two human arginase genes in hyperargininemia. Enzymatic, pathologic, and molecular analysis.

Authors:  W W Grody; C Argyle; R M Kern; G J Dizikes; E B Spector; A D Strickland; D Klein; S D Cederbaum
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

3.  Homocitrullinuria and homoargininuria in hyperargininaemia.

Authors:  T Kato; M Sano; N Mizutani; C Hayakawa
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

Review 4.  Arginase-1 deficiency.

Authors:  Yuan Yan Sin; Garrett Baron; Andreas Schulze; Colin D Funk
Journal:  J Mol Med (Berl)       Date:  2015-10-14       Impact factor: 4.599

5.  Erythrocyte arginase activity as an indicator of lead exposure.

Authors:  K Fukumoto; I Karai; Y Nishikawa; S Horiguchi
Journal:  Br J Ind Med       Date:  1983-02

6.  Arginase activity in fibroblasts.

Authors:  S D Cederbaum; E B Spector
Journal:  Am J Hum Genet       Date:  1978-01       Impact factor: 11.025

7.  Expression of human liver arginase in Escherichia coli. Purification and properties of the product.

Authors:  M Ikemoto; M Tabata; T Miyake; T Kono; M Mori; M Totani; T Murachi
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

8.  Treatment of hyperargininaemia due to arginase deficiency with a chemically defined diet.

Authors:  S D Cederbaum; S J Moedjono; K N Shaw; M Carter; E Naylor; M Walzer
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

9.  Regulation of expression of genes for enzymes of the mammalian urea cycle in permanent cell-culture lines of hepatic and non-hepatic origin.

Authors:  D F Haggerty; E B Spector; M Lynch; R Kern; L B Frank; S D Cederbaum
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

10.  Arginase deficiency manifesting delayed clinical sequelae and induction of a kidney arginase isozyme.

Authors:  W W Grody; R M Kern; D Klein; A E Dodson; P B Wissman; S H Barsky; S D Cederbaum
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.